Revolutionizing oral delivery of biologic therapies
Biologic therapies, essential for treating various chronic and complex diseases, are predominantly administered through injections. This method poses challenges such as patient discomfort, reduced adherence, and increased healthcare costs. Despite their efficacy, the invasive nature of injections limits the full potential of biologics, underscoring a significant need for more patient-friendly delivery methods.
What is the Solution?
Exolvo Biosciences is at the forefront of transforming biologic drug delivery with its innovative ‘smart capsule’ technology. Developed through extensive research within Verily (Google) Life Sciences and originating from the Google X ‘moonshot’ program, these capsules utilize dissolvable microneedles to facilitate the oral administration of large, complex molecules. This approach not only enhances patient comfort by eliminating the need for injections but also ensures the effective delivery of biologics, maintaining their therapeutic efficacy.
By enabling oral delivery, Exolvo’s technology aims to improve patient adherence, reduce healthcare costs associated with injectable therapies, and broaden the accessibility of biologic treatments. The flexibility and modularity of the smart capsules allow for their application across a diverse range of biologic drugs, positioning Exolvo as a leader in the next generation of drug delivery systems.
What EQT Foundation loves about Exolvo Bioscience
Exolvo Biosciences is breaking barriers in healthcare by reimagining how biologic therapies are delivered. Their smart capsule technology is more than just innovative, it’s a game-changer, turning traditionally invasive treatments into something as simple as taking a pill. We love how Exolvo is prioritizing patient comfort while maintaining the effectiveness of life-saving therapies, making biologics more accessible and less daunting. Their vision of transforming healthcare delivery is bold, necessary, and poised to improve the lives of countless patients worldwide. It’s not just about technology—it’s about making treatments truly patient-centered.
ThinQ is the must-bookmark publication for the thinking investor.
More from Library of Hope
Do You Want to Know More?
Get in touch with us and take the first step to successive growth.
Get the Latest Updates
Subscribe to EQT Foundation's press releases and updates.